Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
How Will The Plant-Based Active Pharmaceutical Ingredients (API) Market Valuation Change Between Now And 2029?
The market size of plant-based active pharmaceutical ingredients (API) has experienced significant growth in recent times. It is projected to rise from $ 30.22 billion in 2024 to $ 32.08 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.2%. The substantial growth recorded in the historical phase can be linked to factors such as the rising practice of traditional herbal medicine, increased demand for natural remedies, the expansion of early pharmaceutical formulations, the increasing worldwide trade of medicinal herbs, and the escalation of the industrialization process of botanical drugs.
Anticipations are pointing towards a significant surge in the size of the plant-based active pharmaceutical ingredients (API) market in the coming years. It is projected to expand to “$41.38 billion by 2029, boasting a compound annual growth rate (CAGR) of 6.6%. This predicted growth during the forecast period can be correlated with increasing consumer inclination towards natural medications, augmentation in investments in research focused on plant-based drugs, broadening applications in chronic disease therapies, and growing alliances within pharmaceutical and botanical sectors. Noteworthy trends expected during the forecast period encompass AI-guided drug discovery, sophisticated techniques in plant tissue culture, precision fermentation pertinent to plant-originated compounds, and eco-friendly extraction procedures for sustainable production.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23477&type=smp
What Growth-Enabling Forces Are Impacting The Plant-Based Active Pharmaceutical Ingredients (API) Market?
The increasing inclination of consumers towards natural and organic products is anticipated to fuel the expansion of the plant-based active pharmaceutical ingredients (API) market in the future. Natural and organic products comprise products created with ingredients originating from nature, minimally processed, and devoid of artificial chemicals and genetically modified organisms (GMOs). This rising inclination for natural and organic items stems from enhanced health consciousness and concerns regarding synthetic chemicals. People are growing more aware of the potential hazards linked with synthetic components. Plant-based active pharmaceutical components (APIs) promote natural and organic products by providing efficacious medicinal advantages without chemicals, in harmony with consumer demands for wholesome, safe, and eco-friendly healthcare alternatives. For example, as reported by LETIS S.A., an organic products certification authority based in Argentina, in May 2024, the sale of organic food products skyrocketed to $61.67 billion in 2022, marking a 4.3% surge from the earlier duration, and other organic products contributed $5.906 billion to the overall sales, growing by 1.6%. Thus, the increasing consumer preference for natural and organic products is propelling the growth of the plant-based active pharmaceutical ingredients (API) market.
How Does The Plant-Based Active Pharmaceutical Ingredients (API) Market Differ By Segment?
The plant-based active pharmaceutical ingredients (api) market covered in this report is segmented –
1) By Product Type: Alkaloids, Glycosides, Cannabinoids, Flavonoid, Terpenes And Terpenoids, Polyphenols, Saponins, Other Product Types
2) By Source: Leaves, Roots, Bark, Flowers, Seeds, Fruits, Resin And Gums, Other Sources
3) By Distribution Channel: Online Retailers, Supermarkets Or Hypermarkets, Specialty Food Stores, Foodservice
4) By End-Use: Pharmaceuticals, Nutraceuticals, Herbal Based Industries, Other End-Uses
Subsegments:
1) Alkaloids: Morphine Alkaloids, Tropane Alkaloids, Quinolizidine Alkaloids, Indole Alkaloids, Isoquinoline Alkaloids, Pyrrolizidine Alkaloids
2) By Glycosides: Cardiac Glycosides, Anthraquinone Glycosides, Flavonoid Glycosides, Saponin Glycosides, Cyanogenic Glycosides
3) Cannabinoids: Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG), Cannabichromene (CBC), Cannabinol (CBN)
4) Flavonoid: Flavones, Flavonols, Isoflavones, Flavanones, Anthocyanins
5) Terpenes And Terpenoids: Monoterpenes, Sesquiterpenes, Diterpenes, Triterpenes, Tetraterpenes
6) Polyphenols: Phenolic Acids, Stilbenes, Lignans, Flavonoid Polyphenols
7) Saponins: Steroidal Saponins, Triterpenoid Saponins
8) Other Product Types: Coumarins, Tannins, Lignins, Phenolic Glycosides
What New Opportunities Are Emerging From Trends In The Plant-Based Active Pharmaceutical Ingredients (API) Market?
Leading firms in the plant-based active pharmaceutical ingredients (API) market are directing efforts towards the creation of novel items, such as plant-based squalene, which serve as ethical and sustainable options to the conventional animal-sourced ones. This form of squalene, derived from amaranth, olives, and sugarcane among other plants, is a greener and morally just substitute to shark-sourced squalene and finds application in pharmaceuticals, cosmetics and vaccines. For example, Evonik Industries AG, a Germany-based enterprise specialising in chemicals, introduced PhytoSquene in October 2023. This is the first-ever plant-based squalene, originated from amaranth oil, that meets the GMP-quality standard. The product’s launch provides an environment-friendly alternative to shark-based squalene, while assuring high level of purity, consistent quality across batches, and compliance with European Pharmacopoeia (Ph. Eur.) regulations. Squalene is an important component in vaccine adjuvants as it helps in boosting immune response. PhytoSquene caters to concerns around biodiversity, reduces dependency on animal-derived sources, and aligns with varied cultural and religious sensibilities.
Who Are The Primary Market Leaders In The Plant-Based Active Pharmaceutical Ingredients (API) Market?
Major companies operating in the plant-based active pharmaceutical ingredients (API) market are Evonik Industries AG, Roquette Frères, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Koninklijke DSM NV, Alembic Pharmaceuticals Ltd, Seppic, Indena SpA, PAI Pharma, Centroflora Group, Alkaloids Corporation, SCL Lifesciences Ltd, Alchem International Pvt Ltd, AMGIS Lifescience Ltd, C2 Pharma, PhytoHealth Corp, Bright Green Corporation, Sichuan Xieli Pharmaceutical Co Ltd, Brains Bioceutical Corp, Organotechnie, HimPharm.
Access The Complete Report Here:
Which Region Is Likely To Register The Fastest Growth In The Plant-Based Active Pharmaceutical Ingredients (API) Market?
North America was the largest region in the plant-based active pharmaceutical ingredients (API) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plant-based active pharmaceutical ingredients (API) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=23477&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
